136 related articles for article (PubMed ID: 11861400)
21. Loss of p21 disrupts p14 ARF-induced G1 cell cycle arrest but augments p14 ARF-induced apoptosis in human carcinoma cells.
Hemmati PG; Normand G; Verdoodt B; von Haefen C; Hasenjäger A; Güner D; Wendt J; Dörken B; Daniel PT
Oncogene; 2005 Jun; 24(25):4114-28. PubMed ID: 15750619
[TBL] [Abstract][Full Text] [Related]
22. Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma.
Peng CY; Chen TC; Hung SP; Chen MF; Yeh CT; Tsai SL; Chu CM; Liaw YF
Anticancer Res; 2002; 22(2B):1265-71. PubMed ID: 12168936
[TBL] [Abstract][Full Text] [Related]
23. p14ARF expression increases dihydrofolate reductase degradation and paradoxically results in resistance to folate antagonists in cells with nonfunctional p53.
Magro PG; Russo AJ; Li WW; Banerjee D; Bertino JR
Cancer Res; 2004 Jun; 64(12):4338-45. PubMed ID: 15205349
[TBL] [Abstract][Full Text] [Related]
24. Co-transfection of p16(INK4a) and p53 genes into the K562 cell line inhibits cell proliferation.
Rui HB; Su JZ
Haematologica; 2002 Feb; 87(2):136-42. PubMed ID: 11836163
[TBL] [Abstract][Full Text] [Related]
25. Alterations of the INK4a-ARF gene locus in pleomorphic adenoma of the parotid gland.
Weber A; Langhanki L; Schütz A; Wittekind C; Bootz F; Tannapfel A
J Pathol; 2002 Nov; 198(3):326-34. PubMed ID: 12375265
[TBL] [Abstract][Full Text] [Related]
26. The ARF tumor suppressor inhibits BCL6-mediated transcriptional repression.
Suzuki H; Kurita M; Mizumoto K; Moriyama M; Aiso S; Nishimoto I; Matsuoka M
Biochem Biophys Res Commun; 2005 Jan; 326(1):242-8. PubMed ID: 15567177
[TBL] [Abstract][Full Text] [Related]
27. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
[TBL] [Abstract][Full Text] [Related]
28. [Cyclin-dependent kinase 4 inhibitor a and tumor].
Gong Z; Fu J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Jun; 18(3):219-21. PubMed ID: 11402455
[TBL] [Abstract][Full Text] [Related]
29. Frequent alteration of p16(INK4a)/p14(ARF) and p53 pathways in the round cell component of myxoid/round cell liposarcoma: p53 gene alterations and reduced p14(ARF) expression both correlate with poor prognosis.
Oda Y; Yamamoto H; Takahira T; Kobayashi C; Kawaguchi K; Tateishi N; Nozuka Y; Tamiya S; Tanaka K; Matsuda S; Yokoyama R; Iwamoto Y; Tsuneyoshi M
J Pathol; 2005 Dec; 207(4):410-21. PubMed ID: 16177957
[TBL] [Abstract][Full Text] [Related]
30. p16INK4a modulates p53 in primary human mammary epithelial cells.
Zhang J; Pickering CR; Holst CR; Gauthier ML; Tlsty TD
Cancer Res; 2006 Nov; 66(21):10325-31. PubMed ID: 17079452
[TBL] [Abstract][Full Text] [Related]
31. p14ARF protein expression is a predictor of both relapse and survival in squamous cell carcinoma of the anterior tongue.
Kwong RA; Kalish LH; Nguyen TV; Kench JG; Bova RJ; Cole IE; Musgrove EA; Sutherland RL
Clin Cancer Res; 2005 Jun; 11(11):4107-16. PubMed ID: 15930346
[TBL] [Abstract][Full Text] [Related]
32. Mutant p53 induces the GEF-H1 oncogene, a guanine nucleotide exchange factor-H1 for RhoA, resulting in accelerated cell proliferation in tumor cells.
Mizuarai S; Yamanaka K; Kotani H
Cancer Res; 2006 Jun; 66(12):6319-26. PubMed ID: 16778209
[TBL] [Abstract][Full Text] [Related]
33. Expression of retinoblastoma protein and P16 proteins in classic Hodgkin lymphoma: relationship with expression of p53 and presence of Epstein-Barr virus in the regulation of cell growth and death.
Kim LH; Peh SC; Poppema S
Hum Pathol; 2006 Jan; 37(1):92-100. PubMed ID: 16360421
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of cell-cycle effectors of proliferation in bladder tumor epithelial cells by the p75NTR tumor suppressor.
Khwaja F; Djakiew D
Mol Carcinog; 2003 Mar; 36(3):153-60. PubMed ID: 12619038
[TBL] [Abstract][Full Text] [Related]
35. p53-induced apoptosis as a safeguard against cancer.
Asker C; Wiman KG; Selivanova G
Biochem Biophys Res Commun; 1999 Nov; 265(1):1-6. PubMed ID: 10548481
[TBL] [Abstract][Full Text] [Related]
36. p16 INK4a can initiate an autonomous senescence program.
Dai CY; Enders GH
Oncogene; 2000 Mar; 19(13):1613-22. PubMed ID: 10763818
[TBL] [Abstract][Full Text] [Related]
37. The INK4a/ARF network in tumour suppression.
Sherr CJ
Nat Rev Mol Cell Biol; 2001 Oct; 2(10):731-7. PubMed ID: 11584300
[TBL] [Abstract][Full Text] [Related]
38. Induction of the human ARF protein by serum starvation.
Inoue R; Asker C; Klangby U; Pisa P; Wiman KG
Anticancer Res; 1999; 19(4B):2939-43. PubMed ID: 10652576
[TBL] [Abstract][Full Text] [Related]
39. [P53, ARF and P16: the last defence against reprogrammation].
Dijon-Grinand M; De Vos J
Med Sci (Paris); 2009 Oct; 25(10):793-4. PubMed ID: 19849977
[No Abstract] [Full Text] [Related]
40. Arf and p53 act as guardians of a quiescent cellular state by protecting against immortalization of cells with stable genomes.
Osawa T; Atsumi Y; Sugihara E; Saya H; Kanno M; Tashiro F; Masutani M; Yoshioka K
Biochem Biophys Res Commun; 2013 Mar; 432(1):34-9. PubMed ID: 23376716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]